Kezar Life Sciences Inc Live Share Price Today, Share Analysis and Chart

Name: Kezar Life Sciences Inc: Is Infosys Ltd. worth buying?
Item: Kezar Life Sciences Inc
Rating: 1.57366675
Author: Trendlyne DVM scores

about

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetom...

4.58 0.09 (2.00%)

50.11% Fall from 52W High

22,529

XNAS Volume

XNAS 03 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

15.7 / 100

Technically Neutral

47.3 / 100

1Yr Price target upside is 173%

2 analysts

Kezar Life Sciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Kezar Life Sciences Inc Live Share Price Today, Share Analysis and Chart

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetom...

50.11% Fall from 52W High

SWOT Analysis

Kezar Life Sciences Inc Live Price Chart